Bdparib Tablet (Rucaparib): PARP Inhibitor Anticancer Therapy | For Ovarian, Fallopian Tube, Primary Peritoneal and BRCA-Related Cancers

Precautions

Bdparib Tablet (Rucaparib) requires careful monitoring because it may affect blood cell counts, liver function, and overall health during treatment. Following your doctor's instructions and reporting unusual symptoms early can help manage potential risks.

Before You Start

• Discuss your medical history: Inform your doctor about any blood disorders, liver problems, kidney conditions, or other ongoing health issues.

• Share your medicines: Tell your doctor about all medicines, vitamins, and supplements you take, as some may interact with rucaparib.

• Pregnancy and breastfeeding: Discuss these with your doctor, as rucaparib may harm an unborn baby and breastfeeding may need to be avoided during treatment.

• Review your test results: Your doctor may check blood counts and liver function before starting treatment.

While Using It

• Follow the prescribed dose: Take Bdparib exactly as directed. Do not change the dose without medical advice.

• Attend regular checkups: Blood tests may be needed to monitor blood cell counts and liver function.

• Watch for unusual tiredness: Persistent weakness, pale skin, dizziness, or breathlessness may indicate low blood cell counts.

• Stay hydrated: Drink enough fluids, especially if you experience nausea, vomiting, or diarrhoea.

• Use reliable contraception: Discuss appropriate contraception with your doctor during treatment and for the recommended period afterward.

• Do not stop treatment yourself: Contact your doctor if side effects become difficult to manage.

When to Seek Medical Help

• Signs of infection: Report fever, chills, or frequent infections promptly.

• Unusual bruising or bleeding: Seek medical advice if you notice unexplained bruises or bleeding.

• Liver-related symptoms: Report yellowing of the skin or eyes, dark urine, or persistent abdominal pain.

• Severe weakness or breathing difficulties: Seek urgent medical assessment.

Note:

Bdparib Tablet should be used under specialist supervision. Keep up with scheduled blood tests and report new or worsening symptoms. Your doctor may adjust treatment depending on your response and test results.

Usage

• Follow your doctor's instructions: Take Bdparib Tablet (Rucaparib) exactly as prescribed by your cancer specialist.

• Take it consistently: Rucaparib is generally taken twice daily, approximately 12 hours apart. Follow the schedule recommended for your prescribed strength.

• With or without food: You can take the medicine with or without meals. Swallow the tablet whole with water.

• Missed a dose? Skip the missed dose and take your next dose at the usual time. Do not take two doses together.

• If vomiting occurs: Do not take an extra tablet. Continue with your next scheduled dose.

• Check other medicines: Tell your doctor about all medicines and supplements you use, as some may interact with rucaparib.

• Attend regular check-ups: Your doctor may recommend blood tests to monitor blood cell counts, liver function, and your response to treatment.

Uses

Bdparib Tablet contains Rucaparib, a targeted anticancer medicine belonging to a group called PARP inhibitors. It works by blocking certain proteins that help damaged cells repair their DNA, making it harder for susceptible cancer cells to survive and multiply.

• Ovarian cancer: May be prescribed for certain types of ovarian cancer, depending on previous treatment and individual eligibility.

• Fallopian tube cancer: Used in selected cases of cancer affecting the fallopian tubes.

• Primary peritoneal cancer: May help manage certain cancers affecting the lining of the abdomen.

• BRCA-related cancers: May be considered for eligible cancers with specific BRCA gene changes, depending on the approved indication.

• Targeted treatment: Helps limit the ability of susceptible cancer cells to repair DNA damage, supporting disease management.

Conclusion

Bdparib Tablet (Rucaparib) is a targeted treatment used for certain cancers based on the patient's diagnosis, genetic test results, and treatment history. Taking it as prescribed and attending regular medical check-ups are important for monitoring treatment response and managing possible side effects.

Side Effects

Bdparib Tablet contains rucaparib, a medicine belonging to a group called PARP inhibitors. It is used to treat certain types of cancer by interfering with the repair of damaged DNA in cancer cells. Like other medicines, it may cause side effects, although not everyone experiences them. Some effects are manageable, while others may need medical attention.

Common Side Effects

• Nausea: You may feel sick or have an unsettled stomach.

• Tiredness: You may feel unusually weak or have less energy than normal.

• Loss of appetite: You may not feel as hungry as usual.

• Vomiting: Some people may experience an upset stomach with vomiting.

• Constipation or diarrhoea: You may notice changes in your usual bowel movements.

• Changes in taste: Food may taste different or less enjoyable.

• Anaemia: A decrease in red blood cells may leave you feeling tired, weak, or breathless.

Serious Side Effects

• Low blood cell counts: Reduced blood cells may increase the risk of infections, unusual bleeding, or severe tiredness.

• Liver problems: Changes in liver function may occur. Yellowing of the skin or eyes requires prompt medical attention.

• Serious bone marrow problems: Rare conditions such as myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML) may develop.

• Severe allergic reactions: Swelling of the face or throat or difficulty breathing requires emergency care.

• Severe weakness or breathlessness: Unusual exhaustion, fainting, or breathing difficulties should be assessed promptly.

Note: Take Bdparib Tablet only as prescribed by your healthcare professional. Regular blood tests are important to monitor blood cell counts and liver function during treatment. Avoid prolonged sun exposure, as rucaparib may make your skin more sensitive to sunlight. Do not change or stop your dose without medical advice, and inform your doctor if you experience persistent or unusual symptoms.

FAQs

1. What is Bdparib Tablet used for?

Bdparib Tablet contains rucaparib, an anticancer medicine used to treat certain types of ovarian, fallopian tube, prostate, and related cancers in eligible patients.

2. How does Bdparib Tablet work?

Bdparib blocks proteins called PARP that help cells repair damaged DNA. This makes it harder for certain cancer cells to repair themselves and survive.

3. How should I take Bdparib Tablet?

Take Bdparib exactly as prescribed by your cancer specialist. Swallow the tablet with water, with or without food, and follow your prescribed schedule.

4. What are the common side effects of Bdparib Tablet?

Common side effects may include nausea, tiredness, vomiting, changes in appetite, diarrhoea, constipation, and changes in blood cell counts.

5. Can Bdparib Tablet cure cancer?

Bdparib helps control certain cancers in eligible patients, but its effectiveness varies. Your doctor will monitor your response and decide how long treatment should continue.

6. Does Bdparib Tablet require regular blood tests?

Yes. Regular blood tests are important because rucaparib can lower red blood cells, white blood cells, and platelets. Your doctor may adjust treatment based on the results.

7. What should I do if I miss a dose of Bdparib Tablet?

Skip the missed dose and take your next dose at the usual time. Do not take an extra dose to make up for the missed one.

8. Can Bdparib Tablet interact with other medicines?

Yes. Some medicines may affect how rucaparib works or increase side effects. Tell your doctor about all prescription medicines, over-the-counter products, and supplements you take.

9. What precautions should I follow while taking Bdparib Tablet?

Attend all scheduled check-ups and blood tests. Contact your doctor if you develop unusual bruising, persistent fever, severe weakness, or unusual bleeding.

10. How should Bdparib Tablet be stored?

Store Bdparib as directed on its packaging, away from excessive heat and moisture. Keep it in its original packaging and out of the reach of children.

Interactions

Bdparib Tablet is reported to contain rucaparib, a PARP inhibitor used for certain cancers. Other medicines, supplements, and existing health conditions may affect treatment safety or monitoring. Confirm the active ingredient and strength on the product packaging before relying on product-specific information.

1. Blood-Thinning Medicines

Medicines such as warfarin may require closer monitoring because of potential changes in bleeding risk or laboratory results. Inform the healthcare team if you use any blood-thinning medicine.

2. Other Cancer Medicines

Combining rucaparib with other cancer treatments may increase certain side effects or affect treatment response. Use combinations only under specialist supervision.

3. Medicines Affecting Liver Enzymes

Some medicines can affect how the body processes other drugs. Share a complete list of current medicines so the healthcare team can assess possible interactions.

4. Medicines That Affect Blood Cell Counts

Certain medicines may also reduce blood cell counts. Using them alongside rucaparib may require additional blood tests and monitoring.

5. Vitamins and Herbal Supplements

Some supplements may affect treatment safety or interfere with other medicines. Discuss vitamins, herbal products, and nutritional supplements before using them during treatment.

6. Medicines for Other Health Conditions

Medicines for infections, heart conditions, or long-term health problems should be reviewed before treatment begins. Do not stop any regular medicine without medical guidance.

7. Alcohol

Reliable product-specific information is needed to determine whether alcohol may affect your treatment. Ask the treating specialist whether alcohol should be avoided.

Important Advice

Before starting Bdparib Tablet, provide the healthcare team with a complete list of medicines and supplements. The exact interaction profile should be checked against the confirmed active ingredient, strength, and official product information.